Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 1999;19:2807-2811

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Thiagarajan, P.
Right arrow Articles by Benedict, C. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Thiagarajan, P.
Right arrow Articles by Benedict, C. R.
Related Collections
Right arrow Genomics
Right arrow Anticoagulant mechanisms
Right arrow Lipid and lipoprotein metabolism
(Arteriosclerosis, Thrombosis, and Vascular Biology. 1999;19:2807.)
© 1999 American Heart Association, Inc.


Thrombosis

ß2-Glycoprotein I Promotes the Binding of Anionic Phospholipid Vesicles by Macrophages

Perumal Thiagarajan; Anhquyen Le; Claude R. Benedict

From the Divisions of Hematology (P.T., A.L.) and Cardiology (C.R.B.), Department of Internal Medicine, University of Texas Health Sciences Center, Houston.

Correspondence to Perumal Thiagarajan, MD, University of Texas Health Sciences Center, 6431 Fannin St, MSB 5.284, Houston, TX 77030. E-mail perumal{at}heart.med.uth.tmc.edu

Abstract—ß2-Glycoprotein I is a single-chain 50-kDa protein that circulates in plasma at a concentration of {approx}200 µg/mL. Its physiological role remains uncertain, but an important clue is the frequent presence of antibodies to this protein in patients with recurrent thrombosis. We have isolated ß2-glycoprotein I and examined its effect on the binding of phosphatidylserine (PS) vesicles by human monocyte–derived macrophages and by phorbol ester–stimulated THP-1 cells. ß2-Glycoprotein I stimulated the binding of PS vesicles by these cells in a concentration-dependent manner. Vesicles containing other anionic phospholipids, such as cardiolipin, phosphatidic acid, or cardiolipin, inhibited the binding, whereas PC vesicles had no effect. Platelet-derived microvesicles, which contain anionic phospholipid on the outer leaflet of their phospholipid bilayer, also inhibited ß2-glycoprotein I–dependent binding of anionic phospholipid vesicles. The binding is associated with incorporation of phospholipid in the cell membrane and internalization of ß2-glycoprotein I. These findings suggest a physiological function for ß2-glycoprotein I in the clearance of procoagulant anionic phospholipid-containing cell surfaces from the circulation.


Key Words: lupus anticoagulant • antiphospholipid antibody • ß2-glycoprotein I • anionic phospholipid vesicles




This article has been cited by other articles:


Home page
CirculationHome page
M. Merten, S. Motamedy, S. Ramamurthy, F.C. Arnett, and P. Thiagarajan
Sulfatides: Targets for Anti-Phospholipid Antibodies
Circulation, October 28, 2003; 108(17): 2082 - 2087.
[Abstract] [Full Text] [PDF]